CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- 4 Shares withheld for taxes Chief Regulatory Officer gave up 3,843 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 3,976 shares (to pay taxes)
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 17,701 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,508 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 4,473 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 4,473 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,435 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 26,755 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 16,520 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Regulatory Officer gave up 18,360 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 16,628 shares (to pay taxes)
- 4 Shares withheld for taxes Interim CEO & General Counsel gave up 22,809 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 6,903 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Regulatory Officer gave up 2,798 shares (to pay taxes)
Page 2 of 18 · 352 filings